2025-10-15, Wed.

Top Stories       Business       Culture & Life       Science & Technology       World

Lecture

Notification

 

NEWS > Science & Technology


Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

Date: 2025-09-19

BEIJING -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, such as antibody-conjugated lipid nanoparticle (LNP).

Under the terms of the agreement, Biocytogen will provide proprietary, fully human antibodies derived from its RenMice® platform for evaluation in Merck’s antibody-conjugated LNP services. Merck has been granted an exclusive option to acquire rights to selected antibody assets in return for fees and royalties on sales and sublicenses.

“We are excited to collaborate again with Merck to explore the potential of antibody-conjugated lipid-based delivery systems,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “This collaboration highlights the versatility of our fully human antibody platforms and the broad applications of antibodies beyond traditional therapeutics. By combining our antibody discovery expertise with Merck’s established capabilities in LNPs, we look forward to accelerating the development of next-generation nucleic acid delivery solutions.”

“This collaboration will strengthen Merck’s position in providing LNP-based drug delivery solutions.” said Dr. Kahina Lang, Executive Director, Head of Next Gen Drug Delivery at Merck. “We will be able to further improve the targeting specificity with our innovative design of antibody-conjugated LNPs. Our customers will gain access to a more comprehensive portfolio of delivery service offerings.”



 to the Top List of News

SES delivered unprecedented MEO satellite connectivity for French Navy¡¯s Clemenceau 25 mission
KBS Partners with Rimini Street to Accelerate its AI Vision
LSEG Launches Digital Markets Infrastructure Platform for Private Funds, and Facilitates First Transaction
IFF¡¯s Designed Enzymatic Biomaterials¢â Platform Sees First Large-Scale Use in Home Care Applications
PubNub Powers Historic FIFA Club World Cup 2025¢â Broadcast with DAZN, Creating the World¡¯s Largest Virtual Fan Experience
Swedish Commercial Vehicle Giant Picks HCLTech for AI Digital Services, Expands & Renews Strategic Tech Partnership
Home Swing Home: Redefining My Desk Décor With LG¡¯s Smart Monitor Swing

 

Rigaku Launches Sales of the XHEMIS TX-3000, a TXRF Analytical System ...
Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive...
Omdia: LTPO to Surpass LTPS as Dominant Technology for Flexible Smartp...
LG Launches 4K Surgical Monitor With Intelligent Features To Optimize ...
WeFi Technology Group - Opening Finance Access To Technology Distribut...
Power Integrations Rolls Out Reference Design Kit for Solar Race Cars ...
SES and K2 Space to Accelerate Development of Next-Generation MEO Netw...
MEDIPEAU Showcases its Film-Type Wound Dressing Cream at 51st Annual F...
The New Belkin UltraCharge Collection Brings Fast, Stylish Power at 25...
Smart Scent Platform Deepscent AI Competes in Four Categories at CES 2...

 

 

60, Gamasanro 27gil, Guro-gu, Seoul, Korea, e-mail: news@newsji.com

Copyright, NEWSJI NETWORK.